Iron physiology and pathology in pregnancy
妊娠期铁的生理学和病理学
基本信息
- 批准号:10649598
- 负责人:
- 金额:$ 40.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-06-11 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdverse effectsAffectAnemiaAreaBinding ProteinsBiologicalCell DeathCell physiologyChildCountryDataDeveloped CountriesDevelopmentDietEducational workshopEmbryoEndocrineEndotheliumEnsureErythrocytesFerritinFetal DevelopmentFetal Growth RetardationFetusFoundationsFunctional disorderGestational DiabetesHealthHomeostasisHormonalHormonesHumanInfectionInflammationInvestigationIronIron Metabolism DisordersIron OverloadIron Regulatory Protein 1Iron deficiency anemiaLinkLong-Term EffectsMaintenanceMalnutritionMaternal HealthMaternal and Child HealthMediatingMetabolismMolecularMothersMusOxidative StressPathogenesisPathologyPathway interactionsPhysiologicalPhysiologyPlacentaPoliciesPregnancyPregnancy ComplicationsPregnant WomenPremature BirthPreventionRegulationResearch PriorityRiskRoleSamplingScienceShapesSourceSupplementationTrace metalUnited States National Institutes of Healthabsorptionadverse outcomeadverse pregnancy outcomedesignepidemiology studyfetalhealthy pregnancyhepcidinimprovediron deficiencyiron supplementationmalformationmetal transporting protein 1mouse modeloxygen transportplacental transferpregnancy disorderpreservationresponsescreeningsuccesstrophoblast
项目摘要
PROJECT SUMMARY
Adequate iron availability during pregnancy is essential for fetal development and maternal health. Iron deficiency
and its most common manifestation, anemia, are highly prevalent during pregnancy and can have adverse effects on
the mother and the fetus. Recognition of detrimental effects of iron deficiency has led to the policy of universal
iron supplementation in many countries including the US. However, in developed countries, more pregnant
women are iron-replete than iron-deficient. Indiscriminate iron supplementation in this setting may be not only
unnecessary, but may even have harmful effects related to increased oxidative stress or potential adverse
interaction with inflammation. Despite its importance, little is known about the basic physiology of iron regulation
during pregnancy, or how it is altered in complicated pregnancies.
Specific Aim 1. We will define the role of maternal and fetal hepcidin in regulating iron homeostasis during
pregnancy. Our preliminary data in mouse models indicate that maternal iron-regulatory hormone hepcidin must
be suppressed during pregnancy to ensure sufficient iron availability for placental transfer, and that trophoblast
is an important source of the hepcidin-suppressive activity. We will identify the mechanism(s) by which maternal
hepcidin is suppressed in healthy pregnancy; and determine whether maternal hepcidin levels are
inappropriately increased in human inflamed pregnancies to promote maternal iron restriction.
Specific Aim 2. Our preliminary data show that during maternal iron deficiency or excess, placental iron
transporters are regulated to ensure the maintenance of placental iron homeostasis. In response to maternal
iron deficiency in both mice and humans, this mechanism sequesters iron in the placenta at the expense of
providing adequate iron to the fetus, a phenomenon we termed the “selfish placenta”. This has important
implications for understanding the pathogenesis of fetal iron deficiency. We will define the regulatory circuitries
and biological relevance of the selfish placental response in pregnancy.
Specific Aim 3. Our preliminary data in mouse models demonstrate a dramatic adverse interaction between
maternal iron excess and maternal inflammation during pregnancy, targeting placental endothelium, and
resulting in fetal malformations and embryonic lethality. We will define the underlying mechanisms by focusing
on maternal inflammation and pregnancy hormones, as well as placental and fetal inflammation, oxidative stress,
and cell death pathways.
Our proposal will answer fundamental questions about the pathophysiology of maternal and fetal iron regulation
during pregnancy. Long-term, it has the potential to change our approaches to managing iron disorders during
pregnancy.
项目概要
怀孕期间充足的铁供应对于胎儿发育和孕产妇健康至关重要。
其最常见的表现是贫血,在怀孕期间非常普遍,会对胎儿产生不利影响
对母亲和胎儿缺铁造成的痛苦的认识导致了普遍的政策。
包括美国在内的许多国家都补充铁剂,但在发达国家,怀孕的情况较多。
女性铁质充足,而不是缺铁。
不必要的,但甚至可能产生与氧化应激增加或潜在不利影响相关的有害影响
尽管它很重要,但人们对铁调节的基本生理学知之甚少。
怀孕期间,或者怀孕是多么复杂。
具体目标 1. 我们将定义母体和胎儿铁调素在调节铁稳态中的作用
我们在小鼠模型中的初步数据表明,母体铁调节激素铁调素必须。
在怀孕期间受到抑制,以确保有足够的铁用于胎盘移植,并且滋养层
是铁调素抑制活性的重要来源,我们将确定母体的机制。
健康妊娠时铁调素受到抑制;并确定母体铁调素水平是否正常
人类炎症妊娠中不当增加铁含量以促进母体铁限制。
具体目标 2. 我们的初步数据表明,在母亲铁缺乏或过量期间,胎盘铁
调节转运蛋白以确保维持胎盘铁稳态以响应母体。
小鼠和人类都缺乏铁,这种机制将铁隔离在胎盘中,但以牺牲铁为代价。
为胎儿提供足够的铁,这种现象我们称之为“自私胎盘”,这一点很重要。
对理解胎儿缺铁发病机制的影响我们将定义调节电路。
以及怀孕期间自私胎盘反应的生物学相关性。
具体目标 3. 我们在小鼠模型中的初步数据表明,
怀孕期间母体铁过剩和母体炎症,针对胎盘内皮,以及
导致胎儿畸形和胚胎致死的潜在机制。
对母体炎症和妊娠激素,以及胎盘和胎儿炎症、氧化应激、
和细胞死亡途径。
我们的提案将回答有关母体和胎儿铁调节的病理生理学的基本问题
从长远来看,它有可能改变我们在怀孕期间处理铁失调的方法。
怀孕。
项目成果
期刊论文数量(28)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Effects of maternal iron status on placental and fetal iron homeostasis.
母体铁状态对胎盘和胎儿铁稳态的影响。
- DOI:10.1172/jci127341
- 发表时间:2019-12-17
- 期刊:
- 影响因子:0
- 作者:Veena Sangkhae;Allison L. Fisher;Shirley Wong;M. D. Koenig;L. Tussing;Alison Chu;M. Lelić;T. Ganz;E. Nemeth
- 通讯作者:E. Nemeth
Clinical Immunoassay for Human Hepcidin Predicts Iron Deficiency in First-Time Blood Donors.
人铁调素的临床免疫测定可预测首次献血者的铁缺乏症。
- DOI:
- 发表时间:2020-09-01
- 期刊:
- 影响因子:0
- 作者:Gutschow, Patrick;Han, Huiling;Olbina, Gordana;Westerman, Keith;Nemeth, Elizabeta;Ganz, Tomas;Copeland, Karen;Westerman, Mark;Ostland, Vaughn
- 通讯作者:Ostland, Vaughn
Lung Iron Overload Does Not Exacerbate the Fibrotic Response to Bleomycin in a Mouse Model of Pulmonary Fibrosis.
肺铁过载不会加剧肺纤维化小鼠模型对博莱霉素的纤维化反应。
- DOI:
- 发表时间:2020
- 期刊:
- 影响因子:6.4
- 作者:Zhang, Vida;Nemeth, Elizabeta;Kim, Airie
- 通讯作者:Kim, Airie
Placental iron transport: The mechanism and regulatory circuits.
胎盘铁转运:机制和调节回路。
- DOI:10.1016/j.freeradbiomed.2018.07.001
- 发表时间:2019-03
- 期刊:
- 影响因子:7.4
- 作者:Sangkhae V;Nemeth E
- 通讯作者:Nemeth E
Fetal and amniotic fluid iron homeostasis in healthy and complicated murine, macaque, and human pregnancy.
健康和复杂的小鼠、猕猴和人类妊娠中胎儿和羊水铁稳态。
- DOI:
- 发表时间:2020
- 期刊:
- 影响因子:8
- 作者:Fisher, Allison L;Sangkhae, Veena;Presicce, Pietro;Chougnet, Claire A;Jobe, Alan H;Kallapur, Suhas G;Tabbah, Sammy;Buhimschi, Catalin S;Buhimschi, Irina A;Ganz, Tomas;Nemeth, Elizabeta
- 通讯作者:Nemeth, Elizabeta
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elizabeta Nemeth其他文献
Elizabeta Nemeth的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elizabeta Nemeth', 18)}}的其他基金
Adverse Interaction Between Iron Deficiency and Inflammation in Pregnancy
妊娠期缺铁与炎症之间的不良相互作用
- 批准号:
10473544 - 财政年份:2021
- 资助金额:
$ 40.69万 - 项目类别:
Adverse Interaction Between Iron Deficiency and Inflammation in Pregnancy
妊娠期缺铁与炎症之间的不良相互作用
- 批准号:
10303471 - 财政年份:2021
- 资助金额:
$ 40.69万 - 项目类别:
Erythroferrone and Its Impact on Maternal and Neonatal Iron Homeostasis
赤铁酮及其对孕产妇和新生儿铁稳态的影响
- 批准号:
9760279 - 财政年份:2019
- 资助金额:
$ 40.69万 - 项目类别:
The role of iron in atherosclerosis: application of new iron biology
铁在动脉粥样硬化中的作用:新铁生物学的应用
- 批准号:
8208174 - 财政年份:2011
- 资助金额:
$ 40.69万 - 项目类别:
The role of iron in atherosclerosis: application of new iron biology
铁在动脉粥样硬化中的作用:新铁生物学的应用
- 批准号:
8028193 - 财政年份:2011
- 资助金额:
$ 40.69万 - 项目类别:
相似国自然基金
基于真实世界医疗大数据的中西药联用严重不良反应监测与评价关键方法研究
- 批准号:82274368
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
OR10G7错义突变激活NLRP3炎症小体致伊马替尼严重皮肤不良反应的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于隐狄利克雷分配模型的心血管系统药物不良反应主动监测研究
- 批准号:82273739
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于真实世界数据的创新药品上市后严重罕见不良反应评价关键方法研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
D.formicigenerans菌通过调控FoxP3-Treg影响PD-1抑制剂所致免疫相关不良反应的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
- 批准号:
10751106 - 财政年份:2024
- 资助金额:
$ 40.69万 - 项目类别:
Impact of Body Composition and Related Inflammatory and Immune States on Prognosis of Non-Muscle Invasive Bladder Cancer
身体成分及相关炎症和免疫状态对非肌肉浸润性膀胱癌预后的影响
- 批准号:
10674401 - 财政年份:2023
- 资助金额:
$ 40.69万 - 项目类别:
Growth plate-targeted IGF1 to treat Turner Syndrome
生长板靶向 IGF1 治疗特纳综合征
- 批准号:
10819340 - 财政年份:2023
- 资助金额:
$ 40.69万 - 项目类别:
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM) Research Core & MHD-CE
迈阿密大学艾滋病心理健康和艾滋病毒/艾滋病研究中心 - Center for HIV
- 批准号:
10686545 - 财政年份:2023
- 资助金额:
$ 40.69万 - 项目类别:
Examining the effects of Global Budget Revenue Program on the Costs and Quality of Care Provided to Cancer Patients Undergoing Chemotherapy
检查全球预算收入计划对接受化疗的癌症患者提供的护理成本和质量的影响
- 批准号:
10734831 - 财政年份:2023
- 资助金额:
$ 40.69万 - 项目类别: